Induction of apoptosis in Kaposi's sarcoma spindle cell cultures by the subunits of human chorionic gonadotropin

AIDS

Volumn 11, Issue 11, 1997, Pages 1333-1340

  Lang, Monika E ^a   Lottersberger, Clemens ^a   Roth, Birgit ^a   Böck, Günther ^a   Recheis, Heidrun ^a   Sgonc, Roswitha ^a   Stürzl, Michael ^b   Albini, Adriana ^c   Tschachler, Erwin ^d   Zangerle, Robert ^e   Donini, Silvia ^f   Feichtinger, Hans ^a   Schwarz, Siegfried ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF VIENNA   (Austria)

^e Universitatsklinik fuer Dermatologie und Venerologie Innsbruck   (Austria)

^f Serono International SA   (Switzerland)

Author keywords

Apoptosis; Human chorionic gonadotropin; Kaposi's sarcoma

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN ALPHA SUBUNIT; CHORIONIC GONADOTROPIN BETA SUBUNIT; KETONE DERIVATIVE; MESSENGER RNA; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL GROWTH; CELL KILLING; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; KAPOSI SARCOMA; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINDLE CELL;

AMINO ACID CHLOROMETHYL KETONES; ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BETA 2-MICROGLOBULIN; FLOW CYTOMETRY; GONADOTROPINS; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTES; RECEPTORS, LH; RECOMBINANT PROTEINS; RNA, MESSENGER; SARCOMA, KAPOSI; TUMOR CELLS, CULTURED;

EID: 9844227347     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bernstein L, Hamilton AS: The epidemiology of AIDS-related malignancies. Curr Opin Oncol 1993, 5:822-830.
2. Ames J: A review of Kaposi's sarcoma. Adv Cancer Res 1969, 53:73-87.
3. Russel-Jones R, Spaull J, Spry C, Wilson-Jones E: Histogenesis of Kaposi's sarcoma in patients with and without acquired immune deficiency syndrome (AIDS). J Clin Pathol 1986, 39:742-749.
4. Chang Y, Cesarman E, Pessin MS, et al.: Identification of herpes-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266: 1865-1869.
5. Schalling M, Elkman M, Kaaya EE, Linde A, Biberfeld P: A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nature Med 1995, 1:705-706.
6. Beral V: Epidemiology of Kaposi's sarcoma. Cancer Surv 1991, 10:5-22.
7. Lunardi-Iskandar Y, Bryant JL, Zeman RA, et al.: Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 1995, 375:64-68.
8. Gill PS, Lunardi-Iskandar Y, Louie S, et al.: The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. New Engl J Med 1996, 335:1261-1269.
9. Schwarz S, Krude H, Wick G, Berger P: Twelve of fourteen epitopes of receptor-bound human chorionic gonadotropin (hCG) being antibody-inaccessible suggest an extensive involvement of the long extracellular domain of the hCG receptor. Mol Cell Endocrinol 1991, 82:71-79.
10. Schwarz S, Lottersberger C, Krude H, et al.: Structure and function of the hCG receptor: epitope mapping of receptor-bound agonistic and antagonistic forms of human chorionic gonadotropin (hCG) using rat testis and hCG receptor-transfected cells. In Molecular and Cellular Biology of Reproduction. Edited by Spera G, Fabbrini A, Gnessi L, Bardin CW. New York: Raven Press; 1992:63-86.
11. Albini A, Paglieri I, Orengo G, et al.: The β-core fragment of human chorionic gonadotrophin (hCG) inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line. AIDS 1997, 11:713-721.
12. Roth WK, Brandstetter H, Stürzl M: Cellular and molecular features of HIV-associated Kaposi's sarcoma. AIDS 1992, 6:895-913.
13. Schwarz S, Krude H, Nelboeck E, Merz WE, Wick G: Relationship of orientation with affinity and activity of receptor-bound glycosylation variants of human chorionic gonadotropin (hCG), as visualized by monoclonal antibodies (MCA). J Rec Research 1991, 11:437-458.
14. Sgonc R, Wick G: Methods for the detection of apoptosis. Int Arch Allergy Inmunol 1994, 105:327-332.
15. Ishiyama M, Tominaga H, Shiga M, et al.: Novel cell proliferation and cytotoxicity assays using a tetrazolium salt that produces a water-soluble formazan dye. In Vitro Toxicology 1995, 8:87-190.
16. Nicoletti I, Migliorati G, Pagliacci MC, Grignani L, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytomtry. J Immunol Methods 1991, 139:271-279.
17. Sgonc R, Boeck G, Dietrich H, Gruber J, Recheis H, Wick G: Simultaneous determination of cell surface antigens and apoptosis. Trends Genet 1994, 10:41-42.
18. Nagata S: Apoptosis by death factor. Cell 1997, 88:355-365.
19. Slee EA, Zhu H, Chow SC, MacFarland M, Nicholson DW, Cohen GM: Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J 1996, 315:21-24.
20. Connor JF , Birken S, Lustbader JW, Krichevsky A, Chen Y, Canfield R: Recent advances in the chemistry and immunochemistry of human chorionic gonadotropin: impact on clinical measurements. Endocrine Rev 1994, 15:650-683
21. McFarland KC, Sprengel R, Phillips HS, et al.: Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science 1989, 245:494-499.
22. Norman A, Litwack G: Hormones. New York: Academic Press; 1987:483-513.
23. Lapthorn AJ, Harris DC, Littlejohn A, et al.: Crystal structure of human chorionic gonadotropin. Nature 1994, 369:455-461.
24. Sun PD, Davies DR: The cystine-knot growth-factor superfamily. Annu Rev Biophys Biomol Struct 1995, 24:269-291.
25. Acevedo HE, Krichevsky A, Campbell-Acevedo IA, Galyon JC, Buffo MJ, Hartsock RJ: Expression of membrane-associated human chorionic gonadotropin, its subunits, and fragments by cultured human cancer cells. Cancer 1992, 69:1829-1842.
26. Acevedo AE, Tong JY, Hartsock RJ: Human chorionic gonadotropin-beta subunit gene expression in cultured human fetal and cancer cells of different types and origins Cancer 1996, 76:1467-1475.
27. Hay DL: Discordant and variable production of human chorionic gonadotropin and its free alpha- and beta-subunits in early pregnancy. J Clin Endocrinol Metabol 1985, 61:1195-1200.
28. Nagata S, Golstein, P: The fas death factor. Science 1995, 267:1449-1456.
29. Mori S, Murakami-Mori K, Jewett A, Nakamura S, Bonavida B: Resistance of AIDS-associated Kaposi's sarcoma cells to fas-mediated apoptosis. Cancer Res 1996, 56:1874-1879.
30. Witzke J, Reinhardt W, Reiner C, Hoermann R, Heemann U, Philipp F: Beta-human choriogonadotropin therapy and HIV-related Kaposi's sarcoma. Eur J Med Research 1997, 2:1-4.
31. Melmed S, Braunslein GD: Human chorionic gonadotropin stimulates proliferation of Nb2 rat lymphoma cells. J Clin Endocrinol Metab 1983, 56:1068-1070.
32. Mukherjee K, Das S: A placental glycoprotein, human chorionic gonadotropin, as a growth stimulant of murine tumour cells. IRCS Med Sci 1984, 12:1101-1102.
33. Reinisch N, Sitte BA, Kaehler CM, Wiedermann C: Human chorionic gonadotrophin: a chemoattractant for human blood monocytes, neutrophils and lymphocytes. J Endocrinol 1994, 142:167-170.
34. Bourinbaiar, AS, Lee-Huang, SL: Anti-HIV effect of beta subunit of human chorionic gonadotropin in vitro. Immunol Lett 1995, 44:13-18.